The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Amwill Health Care Ltd

Amwill Health Care Ltd

BSE 544353 · NSE AMWILL · ISIN INE0U2L01017 · Group M · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹43.67

+0.39%

BSE close, 28 August 2026

Market cap

₹87.36 cr

2.0 cr shares · Micro cap

Free float

₹23.60 cr

as published

P/E · P/B

7.7× · —

EPS ₹5.71 · BV —

FY25-26 rev / PAT

45.49 / 11.42

₹ cr, as filed

Filings, window

11

1 selected · 9%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹28.91 52-WK HIGH ₹62.99 ₹43.67 43% of range
Against 52-week high-30.7%
Against 52-week low+51.1%
Day change+0.39%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹5.71
Price / earnings7.65×
Price / book—
Book value — derived, price ÷ P/B—
Return on equity—
Operating margin—
Net margin—

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Mar-26 · Q 24.29 7.55 3.77 42.84% 31.07%
Sep-25 · Q 21.21 3.87 1.94 25.98% 18.27%
FY25-26 45.49 11.42 5.71 34.98% 25.11%

Quarter on quarter

Revenue, quarter on quarter
+14.5%
Net profit, quarter on quarter
+95.1%
Operating margin, quarter on quarter
+1,686 bps

Disclosure profile 11 filings in the window

0 median 17.0 p75 · 25 sector max 52 11 22th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Change in Management1
Selected sub-total1
Procedural
AGM / EGM3
General2
Newspaper Publication2
Annual Report1
Compliance Certificate1
Trading Window1
Procedural sub-total10
Total11

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group M, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

11 filings · 1 selected · busiest 2026-08-14

Filing rhythm · the twelve most recent

2026-07-212026-10-08

SelectedProcedural

Filings

11 in the window · 3 earlier on record

  1. 8 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 for the 2nd Quarter ended September 30, 2026 of FY 2026-27.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 28 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of Trading Window Closure for Half Year ending September 30, 2026.

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 25 September 2026 ·

    General

    Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation, 2015

    Intimation for approval of investment in units of Vivriti Vihaan Trust, a scheme of an Alternative Investment Fund registeed under SEBI and in units of Neo Inc ome plus Fund III, a scheme ....

    Company Update / General View filing →

  4. 14 August 2026 ·

    Change in Management

    Change in Management

    Intimation regarding Re-appointment of Manging Directors for the further term of five years pursuant to the approval of the Members at the 9th AGM of Amwill Health Care Limited.

    Company Update / Change in Management View filing →

  5. 14 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Submission of E voting results along with consolidated Scrutinizer's Report for the 9th AGM of Amwill Health Care Limited.

    AGM/EGM / AGM View filing →

  6. 14 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of the proceedings of 09th AGM of Amwill Health Care Limited held on August 14, 2026 .

    AGM/EGM / AGM View filing →

  7. 23 July 2026 ·

    General

    Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation, 2015

    Intimation of approval for opening of fixed Deposit of Rs. 2 crores with Vysya Co-operative Bank.

    Company Update / General View filing →

  8. 23 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication - Notice of 9th Annual General Meeting of Amwill Health Care Limited , evoting and other Information

    Company Update / Newspaper Publication View filing →

  9. 22 July 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report of Amwill Health Care Limited FY 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  10. 22 July 2026 ·

    AGM / EGM

    Notice Of The Ninth Annual General Meeting For The Financial Year 2025-26

    Notice of the Ninth Annual General Meeting for the Financial Year 2025-26 is attched.

    AGM/EGM / AGM View filing →

  11. 21 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisments-9th Annual General Meeting through Video Conferencing/ other Audio -Visual Means ("VC/OAVM") facility.

    Company Update / Newspaper Publication View filing →

RSS feed for Amwill Health Care Ltd · the 50 most recent filings